Treatment noncompliance with orally disintegrating olanzapine tablets

被引：7
|
作者：
Freudenreich, O
机构：
来源：
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2003年 / 48卷 / 05期
关键词：
D O I：
10.1177/070674370304800521
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：353 / 354
页数：2
相关论文
共 50 条
  • [21] Comparison of superdisintegrants in orally disintegrating tablets
    Zhang, Yeli
    Wrzesinski, Amy
    Moses, Marley
    Bertrand, Holly
    Pharmaceutical Technology, 2010, 34 (07) : 54 - 61
  • [22] On the BCS biowaivers of orally disintegrating tablets
    Garcia-Arieta, Alfredo
    Gordon, John
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 66 : 107 - 108
  • [23] PREPARATION OF FAMOTIDINE ORALLY DISINTEGRATING TABLETS
    Olmez, Senem Sevtap
    Vural, Imran
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 65 - 66
  • [24] Onset of action of orally disintegrating olanzapine versus conventional olanzapine
    Reeves, RR
    Torres, RA
    SOUTHERN MEDICAL JOURNAL, 2004, 97 (02) : 212 - 212
  • [25] Dissolution testing of orally disintegrating tablets
    Kraemer, Johannes
    Gajendran, Jayachandar
    Guillot, Alexis
    Schichtel, Julian
    Tuereli, Akif
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (07) : 911 - 918
  • [26] Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets
    Crocq, Marc-Antoine
    Guillon, Marie-Sa
    Bailey, Paul Ernest
    Provost, Dominique
    EUROPEAN PSYCHIATRY, 2007, 22 (07) : 453 - 454
  • [27] Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia
    Reeves, RR
    Torres, RA
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (07) : 699 - 701
  • [28] NATURALISTIC USE OF THE COATED AND ORALLY DISINTEGRATING TABLETS OF OLANZAPINE IN SCHIZOPHRENIC AND BIPOLAR OUTPATIENTS: EUROPEAN BASELINE RESULTS
    Rouillon, F.
    Chartier, F.
    Kraemer, S.
    Lukasiewicz, M.
    Tcherny-Lessenot, S.
    Beal, C.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [29] Rimegepant orally disintegrating tablets in the acute treatment of migraine: a profile of their use
    Kim, Esther S.
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (12) : 547 - 552
  • [30] Rimegepant orally disintegrating tablets in the acute treatment of migraine: a profile of their use
    Esther S. Kim
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2020, 36 : 547 - 552
12345